Home › Type 1 Diabetes
Pag-aaral pangklinika para sa Type 1 Diabetes na nagre-recruit sa U.S.
138 pag-aaral para sa Type 1 Diabetes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Aurora, CO23 pag-aaral
- Boston, MA21 pag-aaral
- Seattle, WA18 pag-aaral
- Chicago, IL16 pag-aaral
- New York City, NY15 pag-aaral
- New Haven, CT15 pag-aaral
- San Francisco, CA14 pag-aaral
- Miami, FL13 pag-aaral
- Indianapolis, IN13 pag-aaral
- Gainesville, FL12 pag-aaral
- Atlanta, GA11 pag-aaral
- Philadelphia, PA11 pag-aaral
- Durham, NC10 pag-aaral
- Minneapolis, MN10 pag-aaral
- Houston, TX9 pag-aaral
- Charlottesville, VA9 pag-aaral
- Nashville, TN8 pag-aaral
- Dallas, TX7 pag-aaral
- Cleveland, OH7 pag-aaral
- Orlando, FL7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Baltimore, MD6 pag-aaral
- San Diego, CA6 pag-aaral
- Kansas City, MO6 pag-aaral
- Buffalo, NY6 pag-aaral
- Los Angeles, CA6 pag-aaral
- Columbus, OH6 pag-aaral
- Jacksonville, FL5 pag-aaral
- Tampa, FL5 pag-aaral
- Detroit, MI5 pag-aaral
- Rochester, MN4 pag-aaral
- Memphis, TN4 pag-aaral
- Mountain View, CA4 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Louisville, KY4 pag-aaral
- St. Louis, MO3 pag-aaral
- Concord, CA3 pag-aaral
- Austin, TX3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- Portland, OR3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California37 pag-aaral
- Colorado24 pag-aaral
- Connecticut16 pag-aaral
- Florida30 pag-aaral
- Georgia13 pag-aaral
- Illinois16 pag-aaral
- Indiana13 pag-aaral
- Kentucky6 pag-aaral
- Maryland6 pag-aaral
- Massachusetts21 pag-aaral
- Michigan8 pag-aaral
- Minnesota13 pag-aaral
- Missouri9 pag-aaral
- New York23 pag-aaral
- North Carolina12 pag-aaral
- Ohio13 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania13 pag-aaral
- Tennessee11 pag-aaral
- Texas16 pag-aaral
- Utah5 pag-aaral
- Virginia10 pag-aaral
- Washington20 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Starting Technology in At Risk Type 1 Diabetes Study
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06453928ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Nagre-recruit
Edad 8 hanggang 21 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05463289A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07803744App-Based Certified Diabetes Education Therapy (AB-CDE)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07282639A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07222332A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07222137Type 1 Diabetes Extension Study
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 35 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Nagre-recruitPhase 2
Edad 18 hanggang 69 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Nagre-recruitPhase 3
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Nagre-recruitPhase 2
Edad 4 hanggang 34 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07216391Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
Nagre-recruit
Edad 16 hanggang 50 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05540704Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Nagre-recruitPhase 2
Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07807280The iLet Experience Study
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06891898A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Nagre-recruitPhase 1/2
Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04786262Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
Nagre-recruit
Edad 8 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05268250Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599982HLA Demographics Study in Adults With Type 1 Diabetes
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06860516Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07254364Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07766811Family Intervention for Black Teens With Type 1 Diabetes
Nagre-recruit
Edad 10 hanggang 14 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06275412Long-Term Outcomes of Teplizumab in Routine Clinical Care
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07360080SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Nagre-recruitPhase 2
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07187531Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.